Patents Assigned to Augmenta Biosciences, Inc.
  • Antibodies for SARS-CoV-2 and uses thereof
    Patent number: 11919944
    Abstract: The disclosure relates generally to the field of immune binding proteins and method for obtaining immune binding proteins from genomic or other sources. The disclosure also relates to anti-SARS-CoV-2 antibodies that have been obtained from subjects who became immune to this coronavirus, and to methods of using these anti-SARS-CoV-2 antibodies. Methods for neutralizing SARS-CoV-2 are disclosed, as well treatments for SARS-COV-2 using the anti-SARS-CoV-2 antibodies.
    Type: Grant
    Filed: May 9, 2021
    Date of Patent: March 5, 2024
    Assignee: Augmenta Biosciences, Inc.
    Inventors: Christopher J. Emig, Rosanna Man Wah Chau, Payam Shahi, Kim-Xuan Nguyen, Yushuan Lai, Robin Emig, John Beaber, Steven Henry, Marco Antonio Mena